With a market cap of $12.7 billion, Tempe, Arizona-based Align Technology, Inc. (ALGN) designs, manufactures, and markets Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States and internationally.
Companies worth $10 billion or more are generally described as “large-cap stocks.” ALGN falls squarely into this category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the medical instruments & supplies industry. ALGN offers CAD/CAM digital services used in dentistry, orthodontics, and dental records storage through its two operating segments, Clear Aligner and CAD/CAM Services.
Shares of ALGN touched their 52-week high of $263.24 on Jul. 18, 2024, and have fallen 31.6% from that peak. They have grown 9.4% over the past three months, outperforming the Health Care Select Sector SPDR Fund’s (XLV) 9.3% fall over the same time frame.
Shares of the company have declined 25.7% over the past 52 weeks, compared to XLV’s 8.7% fall over the same time frame. Moreover, ALGN stock is down 13.7% on a YTD basis, underperforming XLV’s 3.2% fall.
ALGN shares have been trading below their 200-day moving average for the past year and mostly above their 50-day moving average since late April.
On Apr. 30, ALGN shares declined 2.5% following the release of its Q1 results. The company’s revenue came in at $979.3 million, beating Wall Street forecasts of $972.8 million. Its adjusted EPS of $1.52 surpassed Wall Street expectations marginally. ALGN expects revenue in the range of $1.05 billion to $1.07 billion for Q2.
Its peer, Solventum Corporation (SOLV), has surged 10% in 2025 and 36.2% over the past year, outperforming the stock.
Among the 13 analysts covering the ALGN stock, the consensus rating is a “Moderate Buy.” Its mean price target of $234.25 suggests a 30.1% upside potential from current price levels.
On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
Source link